News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Genzyme Corporation (GENZ) CEO Has $22M Conflict of Interest in Sanofi-Aventis (France) (SASY.PA) Buyout



8/9/2010 8:40:19 AM

BNET -- To read the financial press, Sanofi-Aventis‘ (SNY) attempted acquisition of Genzyme (GENZ) is surrounded in mystery: The two sides are far apart on price and investors expect the haggling will take all summer. Will they agree a price or will Sanofi walk away, not willing to overpay?

Read at BNET


comments powered by Disqus
BNET
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES